Northwest Financial Advisors Adicet Bio, Inc. Transaction History
Northwest Financial Advisors
- $136 Billion
- Q1 2024
A detailed history of Northwest Financial Advisors transactions in Adicet Bio, Inc. stock. As of the latest transaction made, Northwest Financial Advisors holds 1,685 shares of ACET stock, worth $2,308. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,685
Previous 1,685
-0.0%
Holding current value
$2,308
Previous $3.19 Million
24.33%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ACET
# of Institutions
107Shares Held
69.5MCall Options Held
13.3KPut Options Held
24.6K-
Orbimed Advisors LLC San Diego, CA11.4MShares$15.7 Million0.61% of portfolio
-
Tang Capital Management LLC San Diego, CA6.41MShares$8.78 Million1.83% of portfolio
-
Balyasny Asset Management LLC Chicago, IL6.18MShares$8.47 Million0.03% of portfolio
-
Rtw Investments, LP New York, NY4.13MShares$5.66 Million0.16% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.11MShares$5.63 Million0.0% of portfolio
About Adicet Bio, Inc.
- Ticker ACET
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,030,800
- Market Cap $54.8M
- Description
- Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...